Clostridium difficile infection (CDI) is the main cause of infectious antibiotic-associated diarrhea with approximately 500,000 infections and $4.8 billion in excess healthcare cost per year in the US1. While diagnosis of C. difficile still remains controversial worldwide, the new IDSA guidelines reaffirm that PCR is the most sensitive method for toxigenic C. difficile detection. Find here the GenePOC highlights.
In our commitment to help healthcare institutions to manage CDI appropriately, we provide a timely and sensitive solution, as well as the support to help build pre-agreed testing criteria for the detection of C. difficile in symptomatic patients.
Read the full IDSA Guidelines: https://academic.oup.com/cid/advance-article/doi/10.1093/cid/cix1085/4855916
Ref 1: https://www.cdc.gov/media/releases/2015/p0225-clostridium-difficile.html